ChatDocto
Find a doctor
White scored tablet

RANEXA 750 mg

RANOLAZINE · prolonged-release tablets

B/60Oral use
See all pack prices
Strength750 mg
Therapeutic classSYSTEME CARDIOVASCULAIRE
ATC codeC01EB18

About this medicine

RANEXA 750 mg prolonged-release tablets is listed in Tunisia's medicine catalog under the active ingredient RANOLAZINE. This page brings together its recorded pack formats, prices and CNAM coverage information.

What is this medicine used for?

Review pending

A reviewed explanation of uses is not yet published for this medicine in this language. Ask a pharmacist for the leaflet for your exact product.

What side effects should I know about?

Review pending

A reviewed side-effect guide is not yet published for this medicine in this language. This does not mean that the medicine has no side effects. Read your product leaflet or ask a pharmacist.

Price by pack

Compare the recorded price for each exact pack. A catalog entry does not confirm pharmacy stock.

  • Pack · B/60

    60 units in this pack

    Price not recorded
    AMM No.
    15463032
    CNAM reference amount
    CNAM status to be confirmed

    Price source: No verified price source is linked to this pack.

    Price effective date not provided

This reference amount is not a guaranteed refund or a personal out-of-pocket estimate. Your coverage conditions must be confirmed separately.

Medicine details

Dosage formprolonged-release tablets
Route of administrationOral use
LaboratoryMenarini International Operation Luxembourg S.A
OriginOriginator
ScheduleA
ATC codeC01EB18 — Ranolazine
Therapeutic classSYSTEME CARDIOVASCULAIRE